This extraordinary formulation of L-Carnitine is made in Tsunami Nutrition's Research & Development laboratories, where it reaches extremely high levels of purity
Images were taken with an oil-immersion 63 lens using the factory settings for mCherry and YFP
In cases where an employer is providing plan coverage for GLP-1 medications for obesity, there are risks and potential unforeseen consequences if the coverage doesnt have a defined plan structure and a managed process for treatment
In general, pharmacies and outsourcing facilities may not compound drugs that are essentially copies of commercially available FDA-approved products, unless certain conditions are met, such as when a drug is on the FDAs drug shortage list or when there is a documented clinical need for an individual patient. The Alliance for Pharmacy Compounding is pushing back on the FDAs crackdown
SLU-PP-332 is a small molecule, not a peptide, so it behaves somewhat differently in solution than a typical lyophilized peptide
Compounding is legal under Section 503A of the FDCA when the brand-name drug is in shortage or when a patient requires a dose or formulation not commercially available
)
